» Articles » PMID: 35769263

Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Overview
Specialty Cell Biology
Date 2022 Jun 30
PMID 35769263
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2, a newly emerged virus described for the first time in late 2019, affects multiple organs in humans, including the pancreas. Here, we present the bilateral link between the pathophysiology of diabetes and COVID-19, with diabetes being COVID-19 comorbidity, and a complication of SARS-CoV-2 infection. Analysis of clinical data indicates that patients with chronic conditions like diabetes are at increased risk of severe COVID-19, hospitalization, ICU admission, and death compared to the healthy subjects. Further, we show that SARS-CoV-2 infection might be also associated with the development of new-onset diabetes and diabetic ketoacidosis. We then discuss the options for studying SARS-CoV-2 infection in pancreatic settings, including the use of human pluripotent stem cell-derived pancreatic organoids. Further, we review the presence of SARS-CoV-2 receptors in different pancreatic cell types and the infection efficiency based on pancreatic sections from COVID-19 patients and primary human islet studies. Finally, we discuss the impact of SARS-CoV-2 infection on human pancreatic cell homeostasis, focusing on β-cells.

Citing Articles

Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus.

Shabestari M, Salari F, Azizi R, Ghadiri-Anari A, Namiranian N BMC Pulm Med. 2025; 25(1):58.

PMID: 39901215 PMC: 11789312. DOI: 10.1186/s12890-025-03529-9.


Is COVID-19 incriminated in new onset type 2 diabetes mellitus in Lebanese adults?.

Jabbour R, Hallit S, Saliby R, Baydoun A, Nakhoul N BMC Res Notes. 2023; 16(1):176.

PMID: 37596697 PMC: 10439538. DOI: 10.1186/s13104-023-06454-4.


Bidirectional Relationship between Glycemic Control and COVID-19 and Perspectives of Islet Organoid Models of SARS-CoV-2 Infection.

Zhang T, Wang N, Zhu L, Chen L, Liu H Biomedicines. 2023; 11(3).

PMID: 36979836 PMC: 10045433. DOI: 10.3390/biomedicines11030856.


Diabetes in all hospitalized cases in Germany 2015-2019 and impact of the first COVID-19 year 2020.

Auzanneau M, Eckert A, Fritsche A, Heni M, Icks A, Mueller-Stierlin A Endocr Connect. 2023; 12(4).

PMID: 36811912 PMC: 10083653. DOI: 10.1530/EC-22-0475.


Could vitamin D supplementation play a role against COVID-19?.

Li B, Yang S, Hou N Front Immunol. 2022; 13:967215.

PMID: 36172345 PMC: 9511139. DOI: 10.3389/fimmu.2022.967215.

References
1.
Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

2.
Hansen J, Baum A, Pascal K, Russo V, Giordano S, Wloga E . Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 2020; 369(6506):1010-1014. PMC: 7299284. DOI: 10.1126/science.abd0827. View

3.
Leiva-Gea I, Sanchez-Alcoholado L, Martin-Tejedor B, Castellano-Castillo D, Moreno-Indias I, Urda-Cardona A . Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study. Diabetes Care. 2018; 41(11):2385-2395. DOI: 10.2337/dc18-0253. View

4.
Coppelli A, Giannarelli R, Aragona M, Penno G, Falcone M, Tiseo G . Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care. 2020; 43(10):2345-2348. DOI: 10.2337/dc20-1380. View

5.
Youk J, Kim T, Evans K, Jeong Y, Hur Y, Hong S . Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2. Cell Stem Cell. 2020; 27(6):905-919.e10. PMC: 7577700. DOI: 10.1016/j.stem.2020.10.004. View